Dimitris P. Kessissoglou

Anti-inflammatory drugs interacting with Zn(II), Cd(II) and Pt(II) metal ions

Complexes of Zn(II), Cd(II) and Pt(II) metal ions with the anti-inflammatory drugs, 1-methyl-5-(p-toluoyl)-1H-pyrrole-2-acetic acid (Tolmetin), alpha-methyl-4-(2-methylpropyl)benzeneacetic acid (Ibuprofen), 6-methoxy-alpha-methylnaphthalene-2-acetic acid (Naproxen) and 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid (indomethacin) have been synthesized and characterized. In the structurally characterized Cd(naproxen)2 complex the anti-inflammatory drugs acts as bidentate chelate ligand coordinatively bound to metal ions through the deprotonated carboxylate group. Crystal data for 1: [C32H26O8Cd], orthorhombic, space group P22(1)2(1), a = 5.693(2) (A), b = 8.760(3) (A), c = 30.74(1) (A), V = 1533(1) A3, Z = 2. Antibacterial and growth inhibitory activity is higher than that of the parent ligands or the platinum(II) diamine compounds.

Copper(II) complexes with phenoxyalkanoic acids and nitrogen donor heterocyclic ligands: structure and bioactivity

The copper complexes with the phenoxyalkanoic acids MCPA, 2,4-D, 2,4,5-T and 2,4-DP in the presence of a nitrogen donor heterocyclic ligand, phen or bipyam, were prepared and characterized. Interaction of Cu(II) with phenoxyalkanoic acids and bipyam leads to dinuclear or uninuclear neutral complexes while in the presence of phen uninuclear neutral or cationic forms have been isolated. The crystal structure of bis(1,10-phenanthroline)(2-methyl-4-chloro-phenoxyacetato)copper(ll) chloride-methanol(1/1)-water(1/0.6), 1 has been determined and refined by least-squares methods using three-dimensional MoK, data. 1 crystallizes in space group P1, in a cell of dimensions a = 14.577(6)A, b = 1 1.665(5) A, c = 12.249(6) A, alpha = 98.38( 1)degrees, beta = 112.18( 1) degrees, gamma = 104.56(1 ) degrees, V= 1,798( 1) A3 and Z= 2. The cyclic voltammograms of uninuclear cationic complexes in dmf exhibit an extra cathodic wave due to the chloride ion. The available evidence supports an increasing antimicrobial effeciency for the cationic complexes.

High nuclearity nickel compounds with three, four or five metal atoms showing antibacterial activity.

The effect on DNA and the antibacterial activity of a series of high nuclearity nickel compounds with three, four and five metal atoms were examined. The compounds have a mixed ligand composition with salicylhydroxamic acid and di-2-pyridyl-ketonoxime as chelate agents. In the trinuclear compound Ni(3)(shi)(2)(Hpko)(2)(py)(2)(1), two metal ions show a square planar geometry while the third one is in an octahedral environment. The compounds with four and five nickel atoms construct metallacrown cores with two distinct connectivities. The tetranuclear vacant metallacrown [12-MC(Ni(II)N(Hshi)2(pko)2)-4](2+) shows the connectivity pattern [-O-Ni-O-N-Ni-N-](2), while the pentanuclear ([Ni(II)][12-MC(Ni(II)N(shi)2(pko)2)-4])(2+) follows the pattern [-Ni-O-N-](4). Two distinct arrangements of the chelates around the ring metal ions were observed; a 6-5-6-5-6-5-6-5 arrangement for the [12-MC(Ni(II)N(Hshi)2(pko)2)-4] core and a 6-6-5-5-6-6-5-5 arrangement for the [12-MC(Ni(II)N(shi)2(pko)2)-4] core. Magnetic variable temperature susceptibility study of the trinuclear compound revealed the presence of one paramagnetic nickel(II) ion with strong crystal field dependence, with D=5.0(4) cm(-1), g(xy)=2.7(3) and g(z)=2.3(3). The effect of the synthesized Ni(II) complexes on the integrity and electrophoretic mobility of nucleic acids was examined. Only compounds 2, 3 and 4 altered the mobility of pDNA, forming high molecular weight concatamers at low concentrations or precipitates at higher concentrations. Antibacterial activity screening of the above compounds suggests that nickel compounds 2, 3 and 4 were the most active and can act as potent antibacterial agents.

Interaction of Zn(II) with quinolone drugs: Structure and biological evaluation

Zinc complexes with the third-generation quinolone antibacterial drugs levofloxacin and sparfloxacin have been synthesized and characterized. The deprotonated quinolones act as bidentate ligands coordinated to zinc ion through the pyridone and a carboxylato oxygen atom. The crystal structures of [bis(aqua)bis(levofloxacinato)zinc(II)], 1, and [bis(sparfloxacinato)(1,10-phenanthroline)zinc(II)], 3, have been determined by X-ray crystallography. The biological activity of the complexes has been evaluated by examining their ability to bind to calf-thymus DNA (CT DNA) by UV spectroscopy and viscosity measurements. UV studies of the interaction of the complexes with DNA have revealed that they can bind to CT DNA probably by the intercalative binding mode which has also been verified by DNA solution viscosity measurements. The DNA binding constants have been also calculated. A competitive study with ethidium bromide (EB) showed that the complexes exhibit the ability to displace the DNA-bound EB indicating that they bind to DNA in strong competition with EB for the intercalative binding site. The interaction of the complexes with human and bovine serum albumin proteins has been studied by fluorescence spectroscopy showing that the complexes exhibit good binding propensity to these proteins having relatively high binding constant values. The biological properties of the complexes have been evaluated in comparison to the previously reported Zn(II) complexes with the first- and second-generation quinolones oxolinic acid and enrofloxacin.

CuII-herbicide complexes: structure and bioactivity

Abstract Copper complexes with the commercial auxin herbicides 2,4-dichlorophenoxy-acetic acid (2,4-D), 3,4-dichlorophenoxy-acetic acid (3,4-D), 2,4,5-trichlorophenoxy-acetic acid (2,4,5-T), 2-methyl-4-chloro-phenoxy-acetic acid (MCPA), 2,3-dichlorophenoxy-acetic acid (2,3-D) and 2-(2,4-dichlorophenoxy)-propanoic acid (2,4-DP) in the presence or not of 2,2′-bipyridine (bipy), an antimicrobial agent, were prepared and characterized. The available evidence supports a dimeric structure for the 2,3-D complex, while the presence of bipy leads to monomeric forms. The solution behaviour of dinuclear complexes in dimethylformamide (DMF) has shown that the complexes are converted to monomeric compounds by the addition of more than 1:2 of bipy. The cyclic voltammograms of dimers in DMF suggest that the complexes retain the dimeric structure in solution. The electron spin resonance spectra of the compound (aqua)(2,2′-bipyridine)bis(2-methyl-4-chloro-phenoxyacetato) copper(II) (I) show features characteristic of the presence of an S = 1 triplet state. The crystal structure of 1 was determined and refined by least-squares methods using three-dimensional Mo Kα data. 1 crystallizes in the space group C2 c , in a cell of dimensions a=40.49(1), b=7.286(3), c=19.617(6) A , β=103.23(1)°, V=5634(3) A 3 , Z=8 . Study of the antimicrobial activity showed that the presence of bipy increases the efficiency 4–8 times.

Host–Guest Interaction of 12‐MC‐4, 15‐MC‐5, and Fused 12‐MC‐4 Metallacrowns with Mononuclear and Binuclear Carboxylato Complexes: Structure and Magnetic Behavior

Interaction of manganese with salicylhydroxamic ligands leads to the formation of the 12-membered metallacrown [Mn(II)(2(2,4-DP)2(HCOO)2]-[12-MC(Mn(III)N(shi)-4](py)6 (2) (H-2,4-DP =2-(2,4-dichlorophenoxy)propionic acid) and the 15-membered metallacrown [Mn(II)(2,4-D)2][15-MC(Mn(III)N(shi)-5](py)6 (1) (H-2,4-D = 2,4-dichlorophenoxyacetic acid). The crystal structure analysis shows that mononuclear and dinuclear alkanoato complexes are accommodated in the cavity of the metallacrown ring. The magnetic behaviour of 1 and 2 and the magnetic behaviour of the fused 12-membered metallacrown [Ni(II)(mcpa)]2-[12-MC(Ni(II)N(shi)2(pko)2-4][12-MC(Ni(II)N(shi)3(pko)-4]-(CH3OH)3(H2O) (3) (Hmcpa = 2-methyl-4-chlorophenoxyacetic acid) have shown that the zero field and/or the population of many energy levels at low temperatures is the reason for the divergence of the susceptibility data at high fields. For compound 3, the ground state is S = 0, with S = 1 and S = 2 low-lying excited states. This leads to a non-Brillouin behaviour of the magnetisation, since the ground state is very close to the excited states.

15-MC-5 manganese metallacrowns hosting herbicide complexes. Structure and bioactivity.

Interaction of manganese with salicylhydroxamic ligands leads to the formation of a series of 15-membered metallacrown Mn(II)(L)(2)[15-MC(Mn(III)N(shi))-5](py)(6) (L=alkanoato ligand). The crystal structure contains a neutral 15-membered metallacrown ring of the type [15-MC(Mn(III)N(shi))-5]. The metallacrown core consists of five Mn(III) and five shi(-3) ligands. The 15-membered metallacrown ring is formed by the succession of five structural moieties of the type [Mn(III)-N-O]. The diversity in the configuration (planar or propeller) for the ring Mn(III) ions gives to the metallacrown core flexibility and simultaneously allows the encapsulation of the sixth Mn(II). The encapsulated Mn(II) is seven-coordinate and is bound to the five hydroximate oxygen donors provided by the metallacrown core, and two oxygen atoms from the carboxylate herbicide ligands. Antibacterial screening data showed that among all the compounds tested, manganese metallacrowns are more active than the simple manganese herbicide or carboxylate complexes while an increase in the efficiency of [15-MC(Mn(III)N(shi))-5] towards the analogous [12-MC(Mn(III)N(shi))-4] can be observed.

HOMO- AND MIXED-VALENCE EPR-ACTIVE TRINUCLEAR MANGANESE COMPLEXES

Abstract The chemistry of manganese has received considerable attention in recent years due to the fact that manganese is believed to be catalytically active in a variety of metalloenzymes. This paper deals with the study of homo- and mixed-valence EPR active trinuclear manganese complexes potential models for the polymanganese oxo centers.

Pseudohalide complexation by manganese 12-metallacrowns-4 complexes

Abstract The reaction of manganese chloride, sodium or potassium thiocyanate and salicylhydroxamic acid in dimethylformamide–methanol solution leads to the formation of the 12-membered metallacrowns [Na(dmf)2]2(SCN)2{[12-MCMn(III)N(shi)-4](dmf)4} (1) and [K(dmf)2]2(SCN)2{[12-MCMn(III)N(shi)-4](dmf)4} (2). The crystal structure analyses of 1 and 2 show that pseudohalide ligands are bound to the ring manganese ions through the N atoms, while the alkaline ions, Na+ or K+, are accommodated at the cavity of the metallacrown ring. The alkali cations are bound to four oxygen atoms of the metallacrown ring and a single axial dmf. The binding of the pseudohalides (SCN−, OCN− and N3−) to the manganese ions of the metallacrown ring is very similar to that observed previously for (NaBr)2 and (KBr)2 metallacrowns; however, unlike the previously described halide complexes, the thiocyante does not form a bridge between the ring and central metal ions. Furthermore, the pseudohalide ligands do not form a second bond to an adjacent metallacrown, thus, single metallacrowns are isolated rather than chains or columns. The affinity of thiocyanate for the metallacrown is approximately equal to chloride and significantly greater than bromide.

Zinc(II) complexes with the quinolone antibacterial drug flumequine: structure, DNA- and albumin-binding

The interaction of Zn(II) with the quinolone antibacterial drug flumequine (Hflmq) in the presence or absence of an N,N′-donor heterocyclic ligand, 2,2′-bipyridine (bipy), is being investigated. Interaction of equimolar quantities of ZnCl2 with flumequine and 2,2′-bipyridine results in the formation of a structurally characterized [Zn(flmq)(bipy)Cl] (2) complex, while excess of flumequine leads to a structurally characterized [Zn(flmq)2(bipy)] (3) compound. The reaction of ZnCl2 with flumequine in the absence of 2,2′-bipyridine leads to formation of complex [Zn(flmq)2(H2O)2] (1). In all these complexes, the deprotonated bidentate flumequinato ligands are coordinated to zinc ions through pyridone and carboxylato oxygens. The complexes exhibit good binding propensity to human or bovine serum albumin protein having relatively high binding constant values. UV study of interaction of the complexes with calf-thymus DNA (CT DNA) has shown that they bind to CT DNA and [Zn(flmq)(bipy)Cl] exhibits the highest binding constant. A competitive study with ethidium bromide (EB) has shown that the complexes can displace DNA-bound EB, indicating that they bind to DNA in strong competition with EB. The complexes bind to CT DNA in an intercalative binding mode which has also been verified by DNA solution viscosity measurements. DNA electrophoretic mobility experiments showed that all complexes bind to pDNA possibly in an intercalative manner resulting in catenanes formation as well as in double-stranded cleavage reflecting (or ending) in the formation of linear DNA.